» Articles » PMID: 33314467

Evaluation of the National Task Group-Early Detection Screen for Dementia: Sensitivity to 'mild Cognitive Impairment' in Adults with Down Syndrome

Overview
Date 2020 Dec 14
PMID 33314467
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The accuracy of the National Task Group-Early Detection Screen for Dementia (NTG-EDSD) was evaluated in a sample of 185 adults with Down syndrome (DS), emphasizing 'mild cognitive impairment (MCI-DS)'.

Method: Knowledgeable informants were interviewed with the NTG-EDSD, and findings were compared to an independent dementia status rating based on consensus review of detailed assessments of cognition, functional abilities and health status (including physician examination).

Results: Results indicated that sections of the NTG-EDSD were sensitive to MCI-DS, with one or more concerns within the 'Memory' or 'Language and Communication' domains being most informative.

Conclusions: The NTG-EDSD is a useful tool for evaluating dementia status, including MCI-DS. However, estimates of sensitivity and specificity, even for detecting frank dementia, indicated that NTG-EDSD findings need to be supplemented by additional sources of relevant information to achieve an acceptable level of diagnostic/screening accuracy.

Citing Articles

Validity of one-time assessments for identifying prodromal Alzheimer's disease in adults with Down syndrome.

Krinsky-McHale S, Kovacs C, Lee J, Listwan T, Pang D, Schupf N Alzheimers Dement (Amst). 2025; 17(1):e70076.

PMID: 39935890 PMC: 11812125. DOI: 10.1002/dad2.70076.


Preliminary translation of 'Reducing Disability in Alzheimer's Disease' among individuals with intellectual disabilities and caregiver dyads.

Ptomey L, Barton K, Swinford E, Bodde A, George A, Gorczyca A J Appl Res Intellect Disabil. 2024; 37(3):e13239.

PMID: 38621995 PMC: 11067498. DOI: 10.1111/jar.13239.


Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.

Gorijala P, Aslam M, Dang L, Xicota L, Fernandez M, Sung Y Alzheimers Dement. 2023; 20(2):1038-1049.

PMID: 37855447 PMC: 10916941. DOI: 10.1002/alz.13506.


Cognitive outcome measures for tracking Alzheimer's disease in Down syndrome.

Fleming V, Hom C, Clare I, Hurd-Thomas S, Krinsky-McHale S, Handen B Int Rev Res Dev Disabil. 2023; 62:227-263.

PMID: 37396708 PMC: 10312212. DOI: 10.1016/bs.irrdd.2022.05.006.


Down syndrome and Alzheimer's disease: A scoping review of functional performance and fall risk.

Washington S, Cler E, Lowery C, Stark S Alzheimers Dement (N Y). 2023; 9(2):e12393.

PMID: 37228575 PMC: 10203538. DOI: 10.1002/trc2.12393.


References
1.
Handen B, Lott I, Christian B, Schupf N, OBryant S, Mapstone M . The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology. Alzheimers Dement (Amst). 2020; 12(1):e12065. PMC: 7396809. DOI: 10.1002/dad2.12065. View

2.
Machulda M, Lundt E, Albertson S, Kremers W, Mielke M, Knopman D . Neuropsychological subtypes of incident mild cognitive impairment in the Mayo Clinic Study of Aging. Alzheimers Dement. 2019; 15(7):878-887. PMC: 6646057. DOI: 10.1016/j.jalz.2019.03.014. View

3.
Haxby J . Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults. J Ment Defic Res. 1989; 33 ( Pt 3):193-210. DOI: 10.1111/j.1365-2788.1989.tb01467.x. View

4.
Parker S, Mai C, Canfield M, Rickard R, Wang Y, Meyer R . Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010; 88(12):1008-16. DOI: 10.1002/bdra.20735. View

5.
Evenhuis H . The natural history of dementia in Down's syndrome. Arch Neurol. 1990; 47(3):263-7. DOI: 10.1001/archneur.1990.00530030029011. View